Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation

NCT04459273 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT04459273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04459273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Biodistribution Study of 68Ga-FAPI-46 in Patients With Different Malignancies: An Exploratory Biodistribution Study With Histopathology Validation
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Phase 1
Overall status
Active, not recruiting
Start date
August 27, 2020
Completion date
July 1, 2027
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder carcinoma, cancer of unknown primary site, cervical carcinoma, cholangiocarcinoma, hematopoietic and lymphoid cell neoplasm, hepatocellular carcinoma, malignant adrenal gland neoplasm, malignant brain neoplasm, malignant pleural neoplasm, malignant skin neoplasm, malignant solid neoplasm, malignant testicular neoplasm, malignant thymus neoplasm, neuroendocrine neoplasm, thyroid gland carcinoma, urothelial carcinoma